Carregant...
Vedolizumab in the treatment of Crohn’s disease of the pouch
BACKGROUND: Our recent study showed the efficacy and safety of vedolizumab in the treatment of chronic antibiotic-refractory pouchitis. However, there are no published studies on its efficacy and safety in Crohn’s disease (CD) of the pouch. The aim of this study was to assess the efficacy and safety...
Guardat en:
| Publicat a: | Gastroenterol Rep (Oxf) |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6101609/ https://ncbi.nlm.nih.gov/pubmed/30151202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/goy014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|